Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 327

1.

Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.

Bradley LM, Gierthy JF, Pentecost BT.

J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):185-96. doi: 10.1016/j.jsbmb.2007.10.006. Epub 2008 Feb 8.

PMID:
18337089
2.

Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.

Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D.

Cell Signal. 2013 Jun;25(6):1395-402. doi: 10.1016/j.cellsig.2013.02.018. Epub 2013 Mar 14.

PMID:
23499909
4.

Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.

Ellis MJ, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME, Cullen KJ.

Mol Endocrinol. 1996 Mar;10(3):286-97.

PMID:
8833657
5.
6.

Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.

Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D.

Mol Endocrinol. 1999 May;13(5):787-96.

PMID:
10319328
8.
9.

erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.

Knowlden JM, Gee JM, Barrow D, Robertson JF, Ellis IO, Nicholson RI, Hutcheson IR.

Breast Cancer Res. 2011 Sep 22;13(5):R93. doi: 10.1186/bcr3018.

10.

Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.

Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA, Ramasharma K, Marshall M, Li CH.

Mol Endocrinol. 1989 Nov;3(11):1701-9.

PMID:
2558302
11.

Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.

Felice DL, El-Shennawy L, Zhao S, Lantvit DL, Shen Q, Unterman TG, Swanson SM, Frasor J.

Endocrinology. 2013 Sep;154(9):3219-27. doi: 10.1210/en.2012-2208. Epub 2013 Jun 19.

12.

Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.

Chakravarti B, Siddiqui JA, Dwivedi SK, Deshpande S, Samanta K, Bhatta RS, Panda G, Prabhakar YS, Konwar R, Sanyal S, Chattopadhyay N.

Mol Cell Endocrinol. 2011 May 16;338(1-2):68-78. doi: 10.1016/j.mce.2011.03.012. Epub 2011 Mar 30.

PMID:
21457754
16.

A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.

Fox EM, Miller TW, Balko JM, Kuba MG, Sánchez V, Smith RA, Liu S, González-Angulo AM, Mills GB, Ye F, Shyr Y, Manning HC, Buck E, Arteaga CL.

Cancer Res. 2011 Nov 1;71(21):6773-84. doi: 10.1158/0008-5472.CAN-11-1295. Epub 2011 Sep 9.

18.

Insulin-like growth factor receptor expression and function in human breast cancer.

Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N.

Cancer Res. 1990 Jan 1;50(1):48-53.

PMID:
2152773
19.

IGF-I and IGF-II expression in human breast cancer xenografts: relationship to hormone independence.

Brünner N, Moser C, Clarke R, Cullen K.

Breast Cancer Res Treat. 1992;22(1):39-45. Review.

PMID:
1421423
20.

Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.

Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK, Lee AV.

Cancer Res. 2001 Aug 1;61(15):5771-7.

Supplemental Content

Support Center